Ann: PAT-DX1 engineering update, page-90

I too would like to think that this is now in oversold territory..........BUT

There has been no official word from PAB as the extent of this issue and whether or not this is easily overcome or not. Directors and CEO's tell us many things but most times the detail that matters is not for all to see.

All we have is a guesstimate that this is going to delay the next few milestones. Inference is made that they know what is going on and in no time they will have this sorted. Is this really the case or is this more than a delay

Being a speculative stock it is no wonder we are seeing such a big sell off............there are no guarantees in this space. We will just have to wait for the next ann for better clarification on how this affects DX-1 and also DX-3 and also toxicology

The market has spoken...............I doubt we will go under 2c based on the info we have but there is a lot more info we know nothing about that could be material as well

Back to hoping the Good Dr. is playing his cards correctly. Keeping us informed and ironing out the ripples. We are not going to have too many chances to get this right so hopefully he is focusing on getting this right albeit a bit later than what he would have liked